Roche Pharma India Launches Tecentriq SC for Lung Cancer
Roche Pharma India has launched Tecentriq (atezolizumab) SC, the country's first subcutaneous immunotherapy for lung cancer. This treatment can be administered in approximately 7 minutes, offering a faster alternative to traditional methods.
Pharma Biz·


